0001415889-23-007376.txt : 20230504
0001415889-23-007376.hdr.sgml : 20230504
20230504183805
ACCESSION NUMBER: 0001415889-23-007376
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230502
FILED AS OF DATE: 20230504
DATE AS OF CHANGE: 20230504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRAY SUSANNAH
CENTRAL INDEX KEY: 0001833453
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36033
FILM NUMBER: 23890588
MAIL ADDRESS:
STREET 1: 10770 WATERIDGE CIRCLE SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theravance Biopharma, Inc.
CENTRAL INDEX KEY: 0001583107
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
BUSINESS PHONE: 650-808-6000
MAIL ADDRESS:
STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET
CITY: GEORGE TOWN, GRAND CAYMAN
STATE: E9
ZIP: KY1-1104
4
1
form4-05042023_100555.xml
X0407
4
2023-05-02
0001583107
Theravance Biopharma, Inc.
TBPH
0001833453
GRAY SUSANNAH
C/O THERAVANCE BIOPHARMA US, INC.
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
0
Ordinary Shares
2023-05-02
4
A
0
9132
0
A
20951
D
Share Option (Right to Buy)
10.95
2023-05-02
4
A
0
22044
0
A
2033-05-01
Ordinary Shares
22044
22044
D
This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.
/s/ Brett A. Grimaud, Attorney-in-Fact
2023-05-04